BiotechTube
Home/Senisca/Dr Adam Clauss
DA

Dr Adam Clauss

Head of Dermatology and Early Preclinical Development

Senisca

Therapeutic Areas

Age-related DiseasesDermatology

Senisca Pipeline

DrugIndicationPhase
Oligonucleotide SenotherapeuticsAge-related diseases (unspecified)Preclinical
Dermatology ProgramsSkin health / age-related dermatological conditionsPreclinical

Leadership Team at Senisca

DS
Dr Sarah Cole
Chief Executive Officer
PL
Professor Lorna Harries
Chief Scientific Officer, Co-founder
DB
Dr Ben Lee
Head of Discovery Research, Co-founder
DT
Dr Tim Schmidt
Chief Development Officer
DA
Dr Alice Ghidini
Head of Oligonucleotide Development
View full Senisca profile